# CSR Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/csr-biotech

- Industry: Medical Devices & Equipment
- Headquarters: Guangzhou, China
- Website: www.csr-biotech.com/
- Latest round: Series B (Mar 10, 2026)
- Investors on record: 1

## About

Based in Guangzhou, China, and founded in 2019, CSR Biotech (Guangzhou) Co., Ltd, doing business as CSR Biotech, is a microscopy instrument manufacturer, focusing on the research and development and application of super-resolution imaging of living cells. It is incubated by Peking University Interdisciplinary Laboratory and has a subsidary in Beijing. The company has set up a cell culture operation laboratory, a cell imaging laboratory, a microscopic imaging technology research and development laboratory and a 10,000-level cleanliness assembly line workshop. CSR Biotech has acquired more than 40 independent intellectual property rights. In March 2026, the firm closed series B funding from Yuexiu Industrial Investment Funds Management.

The company's main business is the research and development, production and sales of super-resolution microscopes. Its main products are HIS-SIM, an intelligent ultra-sensitive super-resolution microscope and SIM-ultimate, an ultra-high spatiotemporal throughput super-resolution microscope. The company also developed MicroscopeX FINER, a universal fluorescence image enhancement software. The company's services include customized imaging detection, data processing, quantitative analysis, visualization, etc. for batch biological samples.

CSR Biotech generates revenue from the sales of super-resolution microscopes and providing biological sample services.

## Funding rounds

- Series B, Mar 10, 2026 — Yuexiu Industrial Investment Funds Management

## Investors

- Yuexiu Industrial Investment Funds Management (https://capitalatlas.ai/funds/yuexiu-industrial-investment-funds-management) — Series B